Ring vaccination with rVSV-ZEBOV under expanded access in response to an outbreak of Ebola virus disease in Guinea, 2016: an operational and vaccine safety report

BACKGROUND: In March, 2016, a flare-up of Ebola virus disease was reported in Guinea, and in response ring vaccination with the unlicensed rVSV-ZEBOV vaccine was introduced under expanded access, the first time that an Ebola vaccine has been used in an outbreak setting outside a clinical trial. Here...

Descripción completa

Detalles Bibliográficos
Autores principales: Gsell, Pierre-Stéphane, Camacho, Anton, Kucharski, Adam J, Watson, Conall H, Bagayoko, Aminata, Nadlaou, Séverine Danmadji, Dean, Natalie E, Diallo, Abdourahamane, Diallo, Abdourahmane, Honora, Djidonou A, Doumbia, Moussa, Enwere, Godwin, Higgs, Elizabeth S, Mauget, Thomas, Mory, Diakite, Riveros, Ximena, Oumar, Fofana Thierno, Fallah, Mosoka, Toure, Alhassane, Vicari, Andrea S, Longini, Ira M, Edmunds, W J, Henao-Restrepo, Ana Maria, Kieny, Marie Paule, Kéïta, Sakoba
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Science ;, The Lancet Pub. Group 2017
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5700805/
https://www.ncbi.nlm.nih.gov/pubmed/29033032
http://dx.doi.org/10.1016/S1473-3099(17)30541-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5700805/
https://www.ncbi.nlm.nih.gov/pubmed/29033032
http://dx.doi.org/10.1016/S1473-3099(17)30541-8

Ejemplares similares